TY - JOUR
T1 - Involvement of dopamine D2 receptors in apomorphine-induced facilitation of forebrain serotonin output
AU - Mendlin, Anna
AU - Martín, Francisco J.
AU - Jacobs, Barry L.
N1 - Funding Information:
This work was supported by the NIMH grant #23433. During the course of this study, FJM was a recipient of an FPI postdoctoral fellowship from the Spanish Government. The authors are grateful to Dr. C.A. Fornal for his helpful comments during the preparation of this manuscript and to Ms. A.J. Reeves for expert technical assistance.
PY - 1998/6/26
Y1 - 1998/6/26
N2 - The effect of systemic administration of the nonselective dopamine receptor agonist apomorphine on efflux of serotonin (5-hydroxytryptamine, 5-HT) in striatum and hippocampus of freely moving rats was examined using in vivo microdialysis. 5-HT efflux was increased by a moderate dose of apomorphine sufficient for a postsynaptic dopaminergic effect (0.5 mg/kg, s.c.), but not by a lower dose (0.1 mg/kg, s.c.), that acts preferentially on presynaptic dopamine receptors. This effect was blocked by a dopamine D2 receptor antagonist raclopride, administered either systemically or locally into striatum, but not by a 5-HT(1A) receptor antagonist N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl) cyclohexanecarboxamide 3HCl (WAY-100635). This indicates that dopamine D2 receptors, and not 5-HT(1A) receptors, mediate the facilitatory effect of apomorphine, and that this effect occurs at the nerve terminal level. Behavioral effects of apomorphine outlasted the concomitant changes in 5-HT efflux, suggesting that these changes resulted from dopaminergic receptor activation, rather than from the drug-induced behavioral arousal. Copyright (C) 1998 Elsevier Science B.V. All rights reserved.
AB - The effect of systemic administration of the nonselective dopamine receptor agonist apomorphine on efflux of serotonin (5-hydroxytryptamine, 5-HT) in striatum and hippocampus of freely moving rats was examined using in vivo microdialysis. 5-HT efflux was increased by a moderate dose of apomorphine sufficient for a postsynaptic dopaminergic effect (0.5 mg/kg, s.c.), but not by a lower dose (0.1 mg/kg, s.c.), that acts preferentially on presynaptic dopamine receptors. This effect was blocked by a dopamine D2 receptor antagonist raclopride, administered either systemically or locally into striatum, but not by a 5-HT(1A) receptor antagonist N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridinyl) cyclohexanecarboxamide 3HCl (WAY-100635). This indicates that dopamine D2 receptors, and not 5-HT(1A) receptors, mediate the facilitatory effect of apomorphine, and that this effect occurs at the nerve terminal level. Behavioral effects of apomorphine outlasted the concomitant changes in 5-HT efflux, suggesting that these changes resulted from dopaminergic receptor activation, rather than from the drug-induced behavioral arousal. Copyright (C) 1998 Elsevier Science B.V. All rights reserved.
KW - 5-HT (5-hydroxytryptamine, serotonin)
KW - 5-HT(1A) autoreceptor
KW - Dopamine
KW - Dopamine D receptor
KW - Microdialysis
KW - Stereotypy
UR - http://www.scopus.com/inward/record.url?scp=0031595102&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031595102&partnerID=8YFLogxK
U2 - 10.1016/S0014-2999(98)00321-5
DO - 10.1016/S0014-2999(98)00321-5
M3 - Article
C2 - 9721020
AN - SCOPUS:0031595102
SN - 0014-2999
VL - 351
SP - 291
EP - 298
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 3
ER -